Search

everythinglearnresearchcommunity

for

Search:↓

A woman developed a severe skin reaction called toxic epidermal necrolysis after taking the antibiotic cephalexin.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

COVID-19 can cause significant hair loss.

The trichoscopy-assisted hair pull test is useful for diagnosing different types of hair loss.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Trichoscopy is a quick, noninvasive method to diagnose hair and scalp disorders, often reducing the need for biopsies.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Alopecia areata incognita causes sudden hair loss but usually improves with topical steroids.

Stem cell serum effectively treated hair loss caused by COVID-19.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Some drugs can cause temporary or permanent hair loss.

Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

Hair loss from telogen effluvium may not happen again after another surgery.

A standardized guideline would improve Telogen Effluvium management.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.